Human Health raises £4.1m in seed funding to expand its artificial intelligence chronic care platform.
The seed round was led by LocalGlobe, Airtree, and Skip Capital.
Human Health develops a precision health operating system that uses artificial intelligence and real-world data to help patients manage chronic conditions.
Human Health has raised £4.1m in a seed funding round led by LocalGlobe, Airtree, and Skip Capital to accelerate the development of its precision health platform.
The company was founded in November 2021 by former Canva product leaders Kate Lambridis and Georgia Vidler. Their platform, a Precision Health OS, combines artificial intelligence with patient-reported data to monitor daily symptoms, aggregate health histories, and help users generate reports for clinicians.
The latest investment also sees participation from prominent figures including Arvind Rajan, Eric Salama, and David Shein. Proceeds will be directed towards enhancing product features, expanding use cases, and scaling the business platform, Human Evidence.
From the founder
"We started Human because healthcare today is reactive and fragmented – people are left piecing together their own answers. Our mission is to flip that on its head by building the world’s most comprehensive precision-health platform. Human combines real-world data, AI, and behavioural science to give every person a clearer picture of their health and the power to change it."
Kate Lambridis
Co-founder at Human Health
Use of funds
- 01Continue product development
Investors
Categories
About the company
Human Health
Human Health builds an artificial intelligence platform that puts patients in control of managing chronic care.